KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Other financing activities: 2010-2024

Historic Other financing activities for Astrana Health (ASTH) over the last 13 years, with FY2024 value amounting to $34.8 million.

  • Astrana Health's Other financing activities rose 2486.36% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.6 million, marking a year-over-year increase of 8144.11%. This contributed to the annual value of $34.8 million for FY2024, which is 5792.65% up from last year.
  • Latest data reveals that Astrana Health reported Other financing activities of $34.8 million as of FY2024, which was up 5792.65% from $22.0 million recorded in FY2023.
  • In the past 5 years, Astrana Health's Other financing activities ranged from a high of $34.8 million in FY2024 and a low of $48000.0 during FY2021
  • Its 4-year average for Other financing activities is $18.2 million, with a median of $19.1 million in 2022.
  • As far as peak fluctuations go, Astrana Health's Other financing activities surged by 3344375.0% in 2022, and later surged by 3688.59% in 2023.
  • Astrana Health's Other financing activities (Annual) stood at $48000.0 in 2021, then skyrocketed by 33443.75% to $16.1 million in 2022, then skyrocketed by 36.89% to $22.0 million in 2023, then skyrocketed by 57.93% to $34.8 million in 2024.
  • Its Other financing activities was $34.8 million in FY2024, compared to $22.0 million in FY2023 and $16.1 million in FY2022.